Capital Health, a hospital network based in New Jersey, has inked a contract with GE Healthcare to install GE's Discovery NM 750b at Capital Health Medical Center - Hopewell in Pennington, N.J.
GE Healthcare has reported a 1 percent increase in fourth quarter revenues to $5.16 billion, and a slight drop—5 percent—in quarter profits to $953 million. However, the yearly revenue in 2011 rose 7 percent in 2011 over 2010—$18.08 billion versus $16.9 billion. Likewise, the healthcare unit’s yearly profits rose 2 percent from $2.74 billion in 2010 to $2.8 billion in 2011.
18F-flutemetamol PET imaging demonstrates strong concordance with histopathology irrespective of timing and sequence of exams in prospective and retrospective settings, and shows promise as a valuable tool to study and possibly facilitate diagnosis of Alzheimer’s disease, both in patients with suspected normal pressure hydrocephalus, and among the wider population, according to a pooled analysis of four studies presented at the 2012 Human Amyloid Imaging (HAI) conference in Miami, Fla.
The global PACS market, valued at $2.8 billion in 2010, is expected to grow at a compound annual growth rate (CAGR) of 10 percent to reach $5.4 billion by 2017, according to a MarketResearch.com report titled “Picture Archiving and Communication Systems (PACS) – Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017.”
The FDA has granted clearances for GE Healthcare's Brivo NM615, a single-head nuclear medicine gamma camera with SPECT capability.
GE Healthcare has paid the U.S. $30 million, plus interest, to settle allegations that a company it acquired in 2004, Amersham Health, had violated the False Claims Act by causing Medicare to overpay for Myoview, a radiopharmaceutical used in certain cardiac diagnostic imaging procedures, according to the U.S. Department of Justice.
Clarient, a GE Healthcare company, and Acorn Research have formed a collaboration around molecular testing of tumor samples.
Written by Douglas Page
The final diagnostic form the evolving hybrid PET/MR tree will take is uncertain, but it has already begun to blossom. Thus, the low-hanging clinical fruit has lured a number of medical centers to early adoption. Experts weigh in on the potential that PET/MR may hold for various neurologic, oncologic and cardiovascular conditions.
Written by Manjula Puthenedam
This article discusses the recent updates in Alzheimer’s detection using amyloid PET radiotracer 18F-flutemetamol, proteins in the cerebrospinal fluid and blood.
In the era of health IT and meaningful use, many providers are looking for a one-stop shop to house all their cardiovascular reporting needs. However, in terms of the cardiovascular information system (CVIS), most users reported that their system was only 65 percent complete, and most are still looking for an all-in-one solution to meet their needs, according to an October KLAS report titled, “Will the Complete CVIS Please Stand Up?”
GE Healthcare has formed a manufacturing agreement with Advanced Accelerator Applications, a pharmaceutical company based in Milan, Italy, and focused on molecular nuclear medicine.
Skeletal imaging with 18F-NaF harnesses both the imaging characteristics of PET and the improved biodistribution of the fluoride tracer in comparison with standard nuclear techniques, resulting in images that can effectively be used to investigate the cause of bone pain in children, according to the September issue of the American Journal of Roentgenology.
Hong Kong Sanatorium & Hospital has selected GE Healthcare’s tri-modality imaging solution—PET/CT + MR.
Health Imaging will host a series of free virtual conferences focused on effective solutions and strategies to meet the economic, informatics and regulatory needs of imaging stakeholders.
Written by Kaitylyn Dymterko
Using both PET and SPECT may have the potential to provide clinically useful data to enable better stratification and favorable treatments for heart failure patients.
Written by James Brice
SPECT and PET-based strategies have started to refine diagnosis and treatment planning for Parkinson’s disease and epilepsy.
While the developing technology is expensive, KLAS, the Orem, Utah-based research firm, found that providers utilizing PET/CT imaging technology save time and improve image resolution, based on a survey of providers. However, GE Healthcare edged out Philips and Siemens in KLAS’ first report on PET/CT vendors, titled “PET/CT 2011: New Technologies in Focus.”
Concord Medical Services and GE Healthcare have signed a memorandum of understating (MOU) to form a preferred strategic partnership in China.
While corporate General Electric announced an increase in 2011 second quarter operating earnings from continuing operations of $3.7 billion, up 18 percent from the second quarter of 2010, the revenues were $35.6 billion for the quarter, down 4 percent from a year ago. However, GE Healthcare’s segment revenues increased 10 percent.
The global market for diagnostic imaging will exceed $24.4 billion by 2016 with a compound annual growth rate of 6 percent from 2009 to 2016, according to a report published by GBI Research.
|
RSS 
